Product Introduction:
Nuroday P SR Tablet combines Clopidogrel (75 mg) and Aspirin (1500 mcg or 1.5 mg) in a sustained-release form. It is primarily prescribed to reduce the risk of heart attack, stroke, and other cardiovascular events by preventing platelet clumping and blood clot formation.
Uses:
-
Prevention of heart attacks and strokes
-
Management of acute coronary syndrome
-
Post angioplasty or stent placement to prevent clotting
-
Reduces risk of blood clots in cardiovascular diseases
Benefits:
-
Dual antiplatelet action enhances prevention of clots
-
Sustained-release formulation provides longer effect
-
Helps maintain smooth blood flow in arteries
-
Reduces complications related to cardiovascular diseases
Composition:
-
Clopidogrel Bisulfate: 75 mg
-
Aspirin: 1500 mcg (1.5 mg) sustained release
Side Effects:
-
Increased risk of bleeding or bruising
-
Stomach upset or ulcers
-
Allergic reactions (rare)
-
Headache or dizziness
Safety Advice:
-
Use only under medical supervision
-
Inform doctor about any bleeding disorders or surgeries
-
Avoid concurrent use with other blood thinners unless prescribed
-
Regular monitoring recommended during therapy
-
Notify healthcare provider if unusual bleeding occurs
